Article ID Journal Published Year Pages File Type
8685133 Journal of Clinical Neuroscience 2018 6 Pages PDF
Abstract
Despite convincing evidence that MGMT promoter methylation status has a strong influence on prognosis; it appears to be a highly underutilized test in United States hospitals.
Keywords
Related Topics
Life Sciences Neuroscience Neurology
Preview
The utilization of MGMT promoter methylation testing in United States hospitals for glioblastoma and its impact on prognosis
Authors
, , , , , ,